Zhang X - Search Results

1

Loss of STAT5A promotes glucose metabolism and tumor growth through miRNA-23a-AKT signaling in hepatocellular carcinoma.

Jiang Y, Tao Y, Zhang X, Wei X, Li M, He X, Zhou B, Guo W, Yin H, Cheng S. Jiang Y, et al. Among authors: zhang x. Mol Oncol. 2021 Feb;15(2):710-724. doi: 10.1002/1878-0261.12846. Epub 2020 Nov 22. Mol Oncol. 2021. PMID: 33155364 Free PMC article.

2

Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.

Zhang X, Wang K, Wang M, Yang G, Ye X, Wu M, Cheng S. Zhang X, et al. Oncotarget. 2017 Apr 25;8(17):29416-29427. doi: 10.18632/oncotarget.15075. Oncotarget. 2017. PMID: 28177886 Free PMC article. Review.

3

Hepatocellular carcinoma with hepatic vein invasion should not be considered a contraindication for liver resection.

Zhang XP, Wang K, Chen ZH, Cheng SQ. Zhang XP, et al. Hepatology. 2018 Feb;67(2):804-805. doi: 10.1002/hep.29665. Epub 2017 Dec 28. Hepatology. 2018. PMID: 29152778 No abstract available.

4

Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis.

Zhang XP, Wang K, Li N, Zhong CQ, Wei XB, Cheng YQ, Gao YZ, Wang H, Cheng SQ. Zhang XP, et al. BMC Cancer. 2017 Dec 28;17(1):902. doi: 10.1186/s12885-017-3895-z. BMC Cancer. 2017. PMID: 29282010 Free PMC article. Review.

5

hPCL3s Promotes Hepatocellular Carcinoma Metastasis by Activating β-Catenin Signaling.

Cai Z, Qian ZY, Jiang H, Ma N, Li Z, Liu LY, Ren XX, Shang YR, Wang JJ, Li JJ, Liu DP, Zhang XP, Feng D, Ni QZ, Feng YY, Li N, Zhou XY, Wang X, Bao Y, Zhang XL, Deng YZ, Xie D. Cai Z, et al. Among authors: zhang xl, zhang xp. Cancer Res. 2018 May 15;78(10):2536-2549. doi: 10.1158/0008-5472.CAN-17-0028. Epub 2018 Feb 26. Cancer Res. 2018. PMID: 29483096

6

Is Sorafenib an Optimal Treatment for Hepatocellular Carcinoma With Macrovascular Invasion or Metastatic Disease?

Zhang XP, Wang K, Guo WX, Chen ZH, Cheng SQ. Zhang XP, et al. Hepatology. 2018 Aug;68(2):786. doi: 10.1002/hep.29862. Hepatology. 2018. PMID: 29500904 No abstract available.

7

Vacuolar Protein Sorting 33B Is a Tumor Suppressor in Hepatocarcinogenesis.

Wang C, Cheng Y, Zhang X, Li N, Zhang L, Wang S, Tong X, Xu Y, Chen GQ, Cheng S, Fan X, Liu J. Wang C, et al. Among authors: zhang l, zhang x. Hepatology. 2018 Dec;68(6):2239-2253. doi: 10.1002/hep.30077. Epub 2018 Nov 5. Hepatology. 2018. PMID: 29729199

8

FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma.

Zhong CQ, Zhang XP, Ma N, Zhang EB, Li JJ, Jiang YB, Gao YZ, Yuan YM, Lan SQ, Xie D, Cheng SQ. Zhong CQ, et al. Cancer Med. 2018 Jun;7(6):2629-2640. doi: 10.1002/cam4.1511. Epub 2018 May 7. Cancer Med. 2018. PMID: 29733540 Free PMC article.

9

PRMT1 Promoted HCC Growth and Metastasis In Vitro and In Vivo via Activating the STAT3 Signalling Pathway.

Zhang XP, Jiang YB, Zhong CQ, Ma N, Zhang EB, Zhang F, Li JJ, Deng YZ, Wang K, Xie D, Cheng SQ. Zhang XP, et al. Cell Physiol Biochem. 2018;47(4):1643-1654. doi: 10.1159/000490983. Epub 2018 Jun 23. Cell Physiol Biochem. 2018. PMID: 29945155 Free article.

10

A serological scoring system to predict lymph node metastasis in patients with hepatocellular carcinoma.

Zhang XP, Gao YZ, Jiang YB, Wang K, Chen ZH, Guo WX, Shi J, Zhang YJ, Chen MS, Lau WY, Cheng SQ. Zhang XP, et al. HPB (Oxford). 2019 Mar;21(3):335-344. doi: 10.1016/j.hpb.2018.07.013. Epub 2018 Aug 10. HPB (Oxford). 2019. PMID: 30104175 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168,136 results

Search Page